Adobe CTO Kevin Lynch resigns

Adobe’s CTO has sailed into the sunset to “pursue other opportunities.” Now, the web is buzzing about what those new opportunities might be.

Brownian motion: Personnel moves within the life sciences

Nile Therapeutics, a Berkeley, Calif., biotech hired Peter Strumph, formerly chief of operations for struggling heart-drug maker CV Therapeutics, as CEO. Nile is currently developing a second-generation natriuretic peptide, CD-NP, for the treatment of heart failure. Here’s hoping it fares better than the first-generation version of this drug, J&J’s Natrecor. The company’s release is here.